Results 211 to 220 of about 27,421 (247)
Some of the next articles are maybe not open access.
Osteoprotegerin and inflammation.
European cytokine network, 2003RANK, RANKL, and OPG have well established regulatory effects on bone metabolism. RANK is expressed at very high levels on osteoclastic precursors and on mature osteoclasts, and is required for differentiation and activation of the osteoclast. The ligand, RANKL binds to its receptor RANK to induce bone resorption.
N, Saidenberg Kermanac'h +4 more
openaire +1 more source
Osteoprotegerin in Primary Hyperparathyroidism
Hormone and Metabolic Research, 2014J, Szymczak, A, Bohdanowicz-Pawlak
openaire +2 more sources
Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
Circulation, 2008Paul Kostenuik +2 more
exaly
The Role of Osteoprotegerin and Its Ligands in Vascular Function
International Journal of Molecular Sciences, 2019Marianne Zeller, Catherine Vergely
exaly

